格隆汇4月8日丨药明合联(02268.HK)宣布,于2026年4月8日,根据2024年股份计划,其已批准向425名承授人(其中三名为董事,而余下422名承授人为集团雇员)授出485.45万股受限制股份,惟须经选定参与者接纳。
格隆汇4月8日丨药明合联(02268.HK)宣布,于2026年4月8日,根据2024年股份计划,其已批准向425名承授人(其中三名为董事,而余下422名承授人为集团雇员)授出485.45万股受限制股份,惟须经选定参与者接纳。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.